CIK 0000727510
- Non-accelerated filer
- Smaller reporting company
Viskase Holdings, Inc.
Sign in to watch- Ticker
- VISK
- Exchange
- OTC
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 222372868
- Phone
- +1 630-874-0700
- Business address
- 333 EAST BUTTERFIELD ROAD, SUITE 400, LOMBARD, IL, 60148
- Former names
- ENZON PHARMACEUTICALS, INC., ENZON PHARMACEUTICALS INC, ENZON PHARMACEUTICALS INC, ENZON PHARMACEUTICAL INC, ENZON INC
- 4 Open-market sale Director sold 30,000 shares at $8.23 ($246,810)
- 4 Exercise or conversion Director acquired 1,255 shares (option exercise)
- 4 Exercise or conversion Director acquired 1,255 shares (option exercise)
- 4 Exercise or conversion Director acquired 1,255 shares (option exercise)
- 4 Exercise or conversion Director acquired 1,255 shares (option exercise)
- 4 Exercise or conversion Director acquired 1,255 shares (option exercise)
- 4 Exercise or conversion Director acquired 1,255 shares (option exercise)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Open-market buy Chairman, CEO & President bought 10,000 shares at an average $6.86 ($68,565)
- 4 Open-market buy EVP-R&D & Chief Scien. Officer bought 3,000 shares at an average $6.87 ($20,605)
- 4 Open-market buy Exec VP Finance, CFO bought 1,000 shares at $6.87 ($6,868)
Page 15 of 28 · 560 filings